<i>Tisochrysis lutea</i> F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling

Pre-metabolic syndrome (pre-MetS) may represent the best transition phase to start treatments aimed at reducing cardiometabolic risk factors of MetS. In this study, we investigated the effects of the marine microalga <i>Tisochrysis lutea</i> F&M-M36 (<i>T. lutea</i>) on cardiometabolic components of...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mario D’Ambrosio, Elisabetta Bigagli, Lorenzo Cinci, Manuela Gencarelli, Sofia Chioccioli, Natascia Biondi, Liliana Rodolfi, Alberto Niccolai, Francesca Zambelli, Annunziatina Laurino, Laura Raimondi, Mario R. Tredici, Cristina Luceri
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-05-01
Col·lecció:	Marine Drugs
Matèries:	microalgae <i>Tisochrysis lutea</i> adipose tissue lipid metabolism thermogenesis β3-adrenergic receptor
Accés en línia:	https://www.mdpi.com/1660-3397/21/5/303
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!